nivolumab,ipilimumab
bms
['cm914', 'biomarker', 'marker ']
 presenting the long awaited cm914 data. very disappointing without a signal of efficacy and significantly increased toxicity. can we identify a biomarker to select patients most likely in need and most likely to benefit. #esmo22 
GU medical oncologist @UCSanDiego, mom, wife, avid runner. Kidney and prostate cancer research. Tweets are my own and not medical advice.